Cite
719 Doxifluridine in advanced colorectal carcinoma. Parallel multicentre randomized phase II trial
MLA
M. Di Bartolomeo, et al. “719 Doxifluridine in Advanced Colorectal Carcinoma. Parallel Multicentre Randomized Phase II Trial.” European Journal of Cancer, vol. 31, Nov. 1995, p. S150. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........925d35fe234a6b5677b8fe6af3207e1f&authtype=sso&custid=ns315887.
APA
M. Di Bartolomeo, M. Moreschi, M.S. Di Maiuta, G. Bordogna, C. Rabbi, Roberto Buzzoni, L. Somma, Sandro Barni, Giovanni Mantovani, Rossana Casaretti, Emilio Bajetta, V.D. Ferrari, M.A. Colleoni, D. Turci, Vittorio Gebbia, C. Gallo Stampino, & G. Marini. (1995). 719 Doxifluridine in advanced colorectal carcinoma. Parallel multicentre randomized phase II trial. European Journal of Cancer, 31, S150.
Chicago
M. Di Bartolomeo, M. Moreschi, M.S. Di Maiuta, G. Bordogna, C. Rabbi, Roberto Buzzoni, L. Somma, et al. 1995. “719 Doxifluridine in Advanced Colorectal Carcinoma. Parallel Multicentre Randomized Phase II Trial.” European Journal of Cancer 31 (November): S150. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........925d35fe234a6b5677b8fe6af3207e1f&authtype=sso&custid=ns315887.